4
Registered trials
1
Recruiting
1
Completed trials
5
Countries active
4
Unique IMPs
100%
Results reported
100%
1 of 1 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).
Top indications
Top IMPs
DEMERECVIRIDAE BACTERIOPHAGE AGAINST KLEBESIELLA PNEUMONIAE (113.073 BP), DREXLERVIRIDAE BACTERIOPHAGE AGAINST KLEBESIELLA PNEUMONIAE (45.423 BP), MYOVIRIDAE BACTERIOPHAGE AGAINST KLEBESIELLA PNEUMONIAE (169.802 BP), MYOVIRIDAE BACTERIOPHAGE AGAINST PSEUDOMONAS AERUGINOSA (65.855 BP), MYOVIRIDAE BACTERIOPHAGE AGAINST PSEUDOMONAS AERUGINOSA (92.792 BP), SIPHOVIRIDAE BACTERIOPHAGE AGAINST PSEUDOMONAS AERUGINOSA (43.020 BP)
2
ELETRIPTAN
1
F44/10, F125/10, F770/05, F510/08, F1245/05
1
SODIUM CHLORIDE
1
All trials
4 totalShowing 1–4 of 4 trials